Cargando…
Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
Glucocorticoids (GC) are an important risk factor for bone fragility in children with serious illnesses, largely due to their direct adverse effects on skeletal metabolism. To better appreciate the natural history of fractures in this setting, over a decade ago the Canadian STeroid-associated Osteop...
Autor principal: | Ward, Leanne M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772619/ https://www.ncbi.nlm.nih.gov/pubmed/33391179 http://dx.doi.org/10.3389/fendo.2020.00576 |
Ejemplares similares
-
The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
por: Zhang, Leiming, et al.
Publicado: (2021) -
Glucocorticoid-Induced Osteoporosis – A Disorder of Mesenchymal Stromal Cells?
por: Hardy, Rowan, et al.
Publicado: (2011) -
When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2021) -
Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats
por: Wang, Hao, et al.
Publicado: (2022) -
Corrigendum: When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis
por: Hayes, Kaleen N., et al.
Publicado: (2022)